semaglutide safety concerns Addressing patient about the 'newness' and long-term of GLP-1 receptor agonists: A clinician's guide to counseling New study finds semaglutide safe

Medicares negotiated price is $245 per month

doi: 10.1016/j.ejphar.2022.175356

The addition of GCGR to GLP-1 is additive but not as powerful as the addition of GIP to GLP-1 - a counterintuitive result given the strength of Retatrutide's glucagon-driven signal, and one that underscores how much of the triple-agonist story is about the combination of the three receptors rather than the magnitude of any single one

We also help patients explore savings options and copay programs when available

Participants lost up to 24.2% of body weight with Retatrutide over 48 weeks, while Cagrilintide alone achieved about 11.8% over 68 weeks